Results 111 to 120 of about 8,883 (145)

PRRSV GP4 subunit vaccine combined with adenovirus heterologous prime-boost immunization strategy induced a significant immune response in mice. [PDF]

BMC Vet Res
Li H, Zhang W, Wang W, Qiao Y, Xu M, Liu Z, Gu X, Wu A, Ma Z, Chen C, Zhang W.   +10 more
europepmc   +1 more source

The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings. [PDF]

JCI Insight, 2022
Valeri V, Sochon A, Cousu C, Chappert P, Lecoeuche D, Blanc P, Weill JC, Reynaud CA.   +7 more
europepmc   +1 more source

Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population. [PDF]

Vaccine X, 2023
Tabatabaeifar S, Vestergaard JM, Würtz ET, Hansen KK, Nielsen KJ, Schlünssen V, Kolstad HA.   +6 more
europepmc   +1 more source

Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization. [PDF]

NPJ Vaccines
Li D, Wang X, Li G, Zhou J, Bian L, Zhao X, Xing L, Zeng J, Cui J, Cui L, Zhang Y, Chen Y.   +11 more
europepmc   +1 more source

Heterologous prime-boost immunization based on a human adenovirus 5 vectored containing Trichinella spiralis Cystatin-like protein elicits protective mucosal immunity in mice. [PDF]

PLoS Negl Trop Dis
Xu N, Wang Y, Xu N, Xiang Z, Wang D, Yu Y, Liu M, Liu X, Tang B, Bai X.   +9 more
europepmc   +1 more source

Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines. [PDF]

Med, 2022
Zhu Y, Lu Y, Zhou C, Tong G, Gao M, Zhan Y, Wang Y, Liang R, Li Y, Gao T, Wang L, Zhang M, Cheng J, Gong J, Wang J, Zhang W, Qi J, Cui M, Zhu L, Xiao F, Zhu L, Xu Y, Zheng Z, Zhou Z, Cheng Z, Hong P.   +25 more
europepmc   +1 more source

Heterologous prime-boost immunization of two-component vaccine candidate PWDVax protected pigs against F18 enterotoxigenic <i>Escherichia coli</i> post-weaning diarrhea. [PDF]

Infect Immun
Zhang C, Li S, Upadhyay I, Vakamalla SSR, Lauder KL, Hansen C, Massey KA, Hayes C, Herndon NL, Zhang W.   +9 more
europepmc   +1 more source

Antibody Response after Homologous and Heterologous Prime-Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort. [PDF]

Vaccines (Basel)
Adnan N, Haq MA, Akter S, Sajal SMSA, Islam MF, Mou TJ, Jamiruddin MR, Jubyda FT, Islam MS, Tuli JF, Liza SM, Hossain S, Islam Z, Ahmed S, Khandker SS, Hossain R, Ahmed MF, Khondoker MU, Azmuda N, Parvez MAK.   +19 more
europepmc   +1 more source

Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice. [PDF]

Sci Transl Med
Cottrell CA, Hu X, Lee JH, Skog P, Luo S, Flynn CT, McKenney KR, Hurtado J, Kalyuzhniy O, Liguori A, Willis JR, Landais E, Raemisch S, Chen X, Baboo S, Himansu S, Diedrich JK, Duan H, Cheng C, Schiffner T, Bader DLV, Kulp DW, Tingle R, Georgeson E, Eskandarzadeh S, Alavi N, Lu D, Sincomb T, Kubitz M, Mullen TM, Yates JR, Paulson JC, Mascola JR, Alt FW, Briney B, Sok D, Schief WR.   +36 more
europepmc   +1 more source

Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand. [PDF]

Vaccine X
Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J.   +9 more
europepmc   +1 more source